Torquetenovirus Serum Load and Long-Term Outcomes in Renal Transplant Recipients
Following transplantation, patients must take immunosuppressive medication for life. Torquetenovirus (TTV) is thought to be marker for immunosuppression, and TTV−DNA levels after organ transplantation have been investigated, showing high TTV levels, associated with increased risk of infect...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/2/440 |